Intarcia announces two presentations at 50th EASD meeting
Intarcia Therapeutics, Inc. announced its participation in the 50th Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place in Vienna September 15 -19.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Industry News Diabetes GLP-1 therapy ITCA 650 Latest News subcutaneous osmotic pump type 2 diabetes Source Type: news
More News: Clinical Trials | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Study